HanJungNCS KRX:107640KOSDAQ
한중엔시에스 · Korean news coverage and regulatory filings, organized.
In Q2 2026, HanJungNCS reported revenue of ₩42.6bn, up 16.9% year on year, and an operating loss of ₩6.9bn. HanJungNCS (한중엔시에스) appeared in 4 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 20 with 3 articles. It was most often mentioned alongside Isu Specialty Chemical, HBL and D&D Pharmatech.
Filing signals New 5% holder Major holder adding Asset deal M&A / stake deal Swung to loss Share pledge Screener
HanJungNCS quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩42.6bn | +16.9% | −₩6.9bn margin −16.3% | −₩2.2bn |
| Q1 2026 | ₩54.7bn | +65.3% | ₩1.4bn margin 2.6% | ₩1.4bn |
| Q4 2025 derived | ₩59.9bn | +8.1% | ₩2.7bn margin 4.6% | ₩4.2bn |
| Q3 2025 | ₩45.9bn | -3.6% | ₩1.5bn margin 3.3% | ₩1.4bn |
| Q2 2025 | ₩36.4bn | -16.5% | ₩398m margin 1.1% | ₩203m |
| Q1 2025 | ₩33.1bn | +8.1% | −₩627m margin −1.9% | −₩956m |
| Q4 2024 derived | ₩55.4bn | +66.0% | ₩5.9bn margin 10.6% | ₩14.7bn |
| Q3 2024 | ₩47.6bn | +65.1% | ₩1.6bn margin 3.3% | ₩943m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
HanJungNCS top stories 2 weeks, by number of outlets
- 1
- 2
- 3
- 4
- 5
- 6
Latest HanJungNCS news Korean headlines
-
[여의도 투자본부 2부] 한중엔시에스 vs 한빛레이저 vs 디앤디파마텍 vs 이수스페셜티케미컬, 공략법은?
1 more on this story · 1 outlets
- [여의도 투자본부 2부] 한중엔시에스 vs 한빛레이저 vs 디앤디파마텍 vs 이수스페셜티케미컬, 공략법은?머니투데이 · Oct 20 07:00
-
[여의도 투자본부 1부] '한중엔시에스, 삼성SDI' 명예의 전당 갈 종목은?
1 more on this story · 1 outlets
- [여의도 투자본부 1부] '한중엔시에스, 삼성SDI' 명예의 전당 갈 종목은?머니투데이 · Oct 15 07:02
-
한중엔시에스, 산업부 '월드클래스 플러스' 선정서 수여식 참여
2 more on this story · 2 outlets
- [더벨]한중엔시에스, 산업부 월드클래스 선정서 수여머니투데이 · Oct 2 09:10
- 한중엔시에스, 산업부 '월드클래스 플러스' 선정디일렉 · Oct 2 11:57